161 related articles for article (PubMed ID: 35709931)
1. BCL2 G quadruplex-binding small molecules: Current status and prospects for the development of next-generation anticancer therapeutics.
Singh M; Gupta R; Comez L; Paciaroni A; Rani R; Kumar V
Drug Discov Today; 2022 Sep; 27(9):2551-2561. PubMed ID: 35709931
[TBL] [Abstract][Full Text] [Related]
2. Folding/unfolding kinetics of G-quadruplexes upstream of the P1 promoter of the human
Cheng Y; Tang Q; Li Y; Zhang Y; Zhao C; Yan J; You H
J Biol Chem; 2019 Apr; 294(15):5890-5895. PubMed ID: 30787104
[TBL] [Abstract][Full Text] [Related]
3. Recent Update on Targeting
Chaudhuri R; Bhattacharya S; Dash J; Bhattacharya S
J Med Chem; 2021 Jan; 64(1):42-70. PubMed ID: 33355454
[TBL] [Abstract][Full Text] [Related]
4. A New G-Quadruplex with Hairpin Loop Immediately Upstream of the Human BCL2 P1 Promoter Modulates Transcription.
Onel B; Carver M; Wu G; Timonina D; Kalarn S; Larriva M; Yang D
J Am Chem Soc; 2016 Mar; 138(8):2563-70. PubMed ID: 26841249
[TBL] [Abstract][Full Text] [Related]
5. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
6. [Determination of the binding of natural products to the human c-myb oncogene promoter G-quadruplex DNA by capillary electrophoresis and electrospray ionization mass spectrometry].
Wang S; Yang Y; Fan S; Li H; David DYC
Se Pu; 2020 Sep; 38(9):1069-1077. PubMed ID: 34213273
[TBL] [Abstract][Full Text] [Related]
7. Perylene and coronene derivatives binding to G-rich promoter oncogene sequences efficiently reduce their expression in cancer cells.
Micheli E; Altieri A; Cianni L; Cingolani C; Iachettini S; Bianco A; Leonetti C; Cacchione S; Biroccio A; Franceschin M; Rizzo A
Biochimie; 2016 Jun; 125():223-31. PubMed ID: 27086081
[TBL] [Abstract][Full Text] [Related]
8. Targeting the BCL2 Gene Promoter G-Quadruplex with a New Class of Furopyridazinone-Based Molecules.
Amato J; Pagano A; Capasso D; Di Gaetano S; Giustiniano M; Novellino E; Randazzo A; Pagano B
ChemMedChem; 2018 Mar; 13(5):406-410. PubMed ID: 29345419
[TBL] [Abstract][Full Text] [Related]
9. Targeting G-Quadruplex DNA for Cancer Chemotherapy.
Debbarma S; Acharya PC
Curr Drug Discov Technol; 2022; 19(3):e140222201110. PubMed ID: 35156574
[TBL] [Abstract][Full Text] [Related]
10. Oxidative lesions modulate G-quadruplex stability and structure in the human BCL2 promoter.
Bielskutė S; Plavec J; Podbevšek P
Nucleic Acids Res; 2021 Feb; 49(4):2346-2356. PubMed ID: 33638996
[TBL] [Abstract][Full Text] [Related]
11. G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting.
Romano F; Di Porzio A; Iaccarino N; Riccardi G; Di Lorenzo R; Laneri S; Pagano B; Amato J; Randazzo A
Expert Opin Ther Pat; 2023 Nov; 33(11):745-773. PubMed ID: 37855085
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a potent Guanidine derivative that selectively binds and stabilizes the human BCL-2 G-quadruplex DNA and downregulates the transcription.
Pandya N; Rani R; Kumar V; Kumar A
Gene; 2023 Jan; 851():146975. PubMed ID: 36261091
[TBL] [Abstract][Full Text] [Related]
13. Why to target G-quadruplexes using peptides: Next-generation G4-interacting ligands.
Sharma T; Kundu N; Kaur S; Shankaraswamy J; Saxena S
J Pept Sci; 2023 Oct; 29(10):e3491. PubMed ID: 37009771
[TBL] [Abstract][Full Text] [Related]
14. Relative stability of G-quadruplex structures: Interactions between the human Bcl2 promoter region and derivatives of carbazole and diphenylamine.
Sheu SY; Huang CH; Zhou JK; Yang DY
Biopolymers; 2014 Oct; 101(10):1038-50. PubMed ID: 24723333
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a fluorescent, long chain-bridged bispurine that selectively targets the c-MYC G-quadruplex.
Hu MH; Lin JH; Huang Q
Bioorg Chem; 2022 May; 122():105750. PubMed ID: 35325695
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein.
González V; Guo K; Hurley L; Sun D
J Biol Chem; 2009 Aug; 284(35):23622-35. PubMed ID: 19581307
[TBL] [Abstract][Full Text] [Related]
17. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the binding of small ligand molecules to a G-quadruplex DNA located in the HIV-1 promoter.
Mitrasinovic PM
J Biomol Struct Dyn; 2018 Jul; 36(9):2292-2302. PubMed ID: 28728523
[TBL] [Abstract][Full Text] [Related]
19. Chelerythrine down regulates expression of VEGFA, BCL2 and KRAS by arresting G-Quadruplex structures at their promoter regions.
Jana J; Mondal S; Bhattacharjee P; Sengupta P; Roychowdhury T; Saha P; Kundu P; Chatterjee S
Sci Rep; 2017 Jan; 7():40706. PubMed ID: 28102286
[TBL] [Abstract][Full Text] [Related]
20. Specific Recognition of Promoter G-Quadruplex DNAs by Small Molecule Ligands and Light-up Probes.
Dhamodharan V; Pradeepkumar PI
ACS Chem Biol; 2019 Oct; 14(10):2102-2114. PubMed ID: 31532996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
